22.02.2013 Views

ANNUAL REPORT 2011 REGISTRATION DOCUMENT - Saft

ANNUAL REPORT 2011 REGISTRATION DOCUMENT - Saft

ANNUAL REPORT 2011 REGISTRATION DOCUMENT - Saft

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

6 Notes<br />

<strong>2011</strong> CONSOLIDATED FINANCIAL STATEMENTS<br />

to the Consolidated Financial Statements<br />

Each technology is amortised by the straight-line method on the<br />

basis of their estimated useful lives and commercial prospects.<br />

The periods used are:<br />

� Lithium-ion 21 years<br />

� Primary Lithium 11 years<br />

� Nickel-Cadmium 11 years<br />

� Nickel-Metal Hydride 7 years<br />

� Other Technologies 4 years<br />

Research and Development costs<br />

Research and Development expenditure is recognised as an<br />

expense in the year in which it is incurred, except for some<br />

development costs that are capitalised as an intangible asset<br />

in accordance with IAS 38 when all of the following six criteria<br />

are strictly met:<br />

� the technical feasibility of completing the intangible asset so<br />

that it will be available for use or sale;<br />

� the intention to complete the intangible asset and use or sell<br />

it;<br />

� the ability to use or sell the intangible asset;<br />

� the existence of a market for the output of the intangible<br />

asset;<br />

� the availability of adequate technical, fi nancial and human<br />

resources to complete the development; and<br />

� the ability to measure the expenditure attributable to the<br />

intangible asset during its development reliably.<br />

The cost of a capitalised development project is the sum of<br />

expenditure incurred from the date when the project fi rst meets<br />

the six criteria listed above. Development expenditure initially<br />

recognised as an expense is not capitalised in subsequent<br />

periods.<br />

Capitalised development costs are amortised over:<br />

� the useful life (of a process) or the commercial life (of a<br />

product), if this can be determined; or<br />

� the useful life of the underlying technology.<br />

Amortisation of capitalised development costs does not start<br />

until the related product begins to be sold.<br />

Capitalised development costs are generally amortised over<br />

a period of between 3 and 21 years. These periods are<br />

reviewed annually, and any adjustments required as a result of<br />

these reviews are recognised prospectively.<br />

Billable Research and Development expenditure incurred under<br />

a contract with a customer is included in long-term contract<br />

work in process.<br />

134 / SAFT - <strong>ANNUAL</strong> <strong>REPORT</strong> <strong>2011</strong><br />

2.9 GOODWILL<br />

In accordance with IFRS 3 “Business combinations”, at the<br />

acquisition date, the difference between the acquisition cost of<br />

the subsidiary and the Group’s interest in its net assets stated at<br />

fair value, is accounted for as goodwill.<br />

Goodwill is not amortised but is tested for impairment as soon<br />

as an indication of potential impairment appears and at least<br />

on an annual basis.<br />

Goodwill is allocated to the Cash Generating Units (CGUs)<br />

or groups of CGUs to which it relates to carry out impairment<br />

tests. In accordance with IAS 36 “Impairment of assets”,<br />

the methodology used by the Group to identify potential<br />

impairments primarily involves comparing the recoverable<br />

amount of each CGU or group of CGUs with the carrying<br />

amount of their respective assets.<br />

The recoverable amount is the higher of the fair value less exit<br />

costs or the value in use determined as the present value of<br />

future cash fl ows associated with the CGU.<br />

Recoverable amounts of CGUs are determined on the basis of:<br />

� projections of cash fl ows generated by operations for the<br />

relevant CGU over its three-year business plan, plus a<br />

terminal value;<br />

� discounting such projected cash fl ows at the Group’s<br />

Weighted Average Cost of capital (WACC).<br />

Any impairment losses identifi ed are charged to the income<br />

statement in the operating profi t. Impairment losses recognised<br />

against goodwill may not be reversed.<br />

Main assumptions and estimates used for these calculations by<br />

the end of <strong>2011</strong> are described in Note 10.<br />

2.10 PROPERTY, PLANT AND EQUIPMENT<br />

In accordance with IAS 16 “Property, Plant and Equipment”<br />

assets are only capitalised if the cost of the asset can be<br />

measured reliably and it is probable that the future economic<br />

benefi ts attributable to the asset will fl ow to the Group.<br />

Items of property, plant and equipment are derecognised<br />

when the risks and rewards incidental to ownership of the asset<br />

are transferred or when there is no future economic benefi t<br />

expected from the asset’s use of sale.<br />

Any gain or loss arising from the derecognition of an asset<br />

(calculated as the difference between the net disposal<br />

proceeds and the carrying amount of the asset) is recognised<br />

in the income statement in the period in which the asset is<br />

derecognised.<br />

Items of property, plant and equipment are initially recognised<br />

at historical cost of acquisition or production.<br />

Property, plant and equipment costs may include, if applicable,<br />

borrowing costs when the asset is eligible under IAS 23 R<br />

(asset requiring a long preparation period before it can be<br />

used or sold).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!